{"id":"W4402559998","doi":"10.1016/j.annonc.2024.08.724","title":"658P First-in-human phase I trial of oncolytic herpes simplex virus ONCR-177 alone or in combination with pembrolizumab in advanced solid tumors","year":2024,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Oncolytic virus; Pembrolizumab; Virology; Herpes simplex virus; Oncology; Cancer research; Internal medicine; Virus; Immunotherapy; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008902323,0.001624498,0.001671648,0.000513252,0.0004252211,0.00123799,0.0007426915,0.001019991,0.004789734],"category_scores_gemma":[0.0004056944,0.0005230762,0.001231782,0.0003684145,0.0009709326,0.0007627779,0.0003620997,0.003169233,0.001103117],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001221775,"about_ca_system_score_gemma":0.001816485,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002595987,"about_ca_topic_score_gemma":0.005532376,"domain_scores_codex":[0.9997551,0.00006966685,0.000008579297,0.00003850475,0.00002350589,0.0001047289],"domain_scores_gemma":[0.9997601,0.00003292164,0.00003068131,0.00002085491,0.00001096441,0.0001445922],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6189254,0.06087925,0.003735022,0.001373969,0.002687836,0.0003838158,0.0005919173,0.006840198,0.09180275,0.001917817,0.01304545,0.1978165],"study_design_scores_gemma":[0.4711606,0.4934891,0.008331168,0.00008462097,0.0009653844,0.0003204866,0.0001920329,0.002253771,0.01328322,0.0007903675,0.009074661,0.00005455491],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9895777,0.002183982,0.0006136357,0.0007135011,0.0002865453,0.001187144,0.001380848,0.000203237,0.003853468],"genre_scores_gemma":[0.9841692,0.002472848,0.001342476,0.0007377591,0.0001182058,0.001367503,0.002164636,0.0000647509,0.007562471],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004789734,"threshold_uncertainty_score":0.01602328,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05677139824352929,"score_gpt":0.4353904370972907,"score_spread":0.3786190388537614,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}